Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:22:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new collaborators and investigators, as well as a revision update to v2.15.0. Notably, the detailed information regarding neuroendocrine tumors and their treatment has been removed.
    Difference
    45%
    Check dated 2025-04-16T10:33:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The estimated last update posted has been removed.
    Difference
    0.1%
    Check dated 2025-04-09T04:59:09.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to indicate that it is now completed, while previously it was noted as active but not recruiting.
    Difference
    0.2%
    Check dated 2025-04-01T22:16:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-24T20:15:06.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:28:49.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.